H

Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566

Watchlist Manager
Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
Watchlist
Price: 26.16 CNY 0.08% Market Closed
Market Cap: 24.1B CNY

Intrinsic Value

The intrinsic value of one Hubei Jumpcan Pharmaceutical Co Ltd stock under the Base Case scenario is 45.09 CNY. Compared to the current market price of 26.16 CNY, Hubei Jumpcan Pharmaceutical Co Ltd is Undervalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
45.09 CNY
Undervaluation 42%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hubei Jumpcan Pharmaceutical Co Ltd

Hubei Jumpcan Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Hubei Jumpcan Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
CN
Pharmaceuticals
Market Cap
24.1B CNY
IPO
Aug 22, 2001
CN
Pharmaceuticals
Market Cap
24.1B CNY
IPO
Aug 22, 2001
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hubei Jumpcan Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Hubei Jumpcan Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hubei Jumpcan Pharmaceutical Co Ltd

Current Assets 14.3B
Cash & Short-Term Investments 11.7B
Receivables 1.9B
Other Current Assets 713.7m
Non-Current Assets 3.8B
Long-Term Investments 453.7m
PP&E 2.8B
Intangibles 481.6m
Other Non-Current Assets 110m
Efficiency

Free Cash Flow Analysis
Hubei Jumpcan Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hubei Jumpcan Pharmaceutical Co Ltd

Revenue
8.9B CNY
Cost of Revenue
-1.9B CNY
Gross Profit
7B CNY
Operating Expenses
-4.3B CNY
Operating Income
2.7B CNY
Other Expenses
42.5m CNY
Net Income
2.8B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hubei Jumpcan Pharmaceutical Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Exceptional ROIC
76/100
Profitability
Score

Hubei Jumpcan Pharmaceutical Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hubei Jumpcan Pharmaceutical Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Short-Term Solvency
86/100
Solvency
Score

Hubei Jumpcan Pharmaceutical Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hubei Jumpcan Pharmaceutical Co Ltd

Wall Street analysts forecast Hubei Jumpcan Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hubei Jumpcan Pharmaceutical Co Ltd is 53.41 CNY with a low forecast of 52.88 CNY and a high forecast of 54.98 CNY.

Lowest
Price Target
52.88 CNY
102% Upside
Average
Price Target
53.41 CNY
104% Upside
Highest
Price Target
54.98 CNY
110% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hubei Jumpcan Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Hubei Jumpcan Pharmaceutical Co Ltd stock?

The intrinsic value of one Hubei Jumpcan Pharmaceutical Co Ltd stock under the Base Case scenario is 45.09 CNY.

Is Hubei Jumpcan Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 26.16 CNY, Hubei Jumpcan Pharmaceutical Co Ltd is Undervalued by 42%.

Back to Top